Shoreline Biosciences
0 followers
‌
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Industries
Headquarters
Employees
Links
Org chart
Kleanthis G. Xanthopoulos
Chairman & CEO
Kleanthis G. Xanthopoulos
Collapse
Robert Hollingsworth
Chief Scientific Officer
Scott Forrest
Chief Business Officer
Mauro P. Avanzi
Chief Medical Officer
Steven Neben
VP, Alliance & Project Management
Paschalis Sideras
VP, Discovery Immunobiology
Krishna Patel
HR Manager
Similar companies
Kyverna Therapeutics
5 followers
St. Francis Xavier Catholic School System
10 followers
UNC Charlotte
6 followers
Forge Biologics
2 followers
Vaxcyte
2 followers
Verve Therapeutics
54 followers
Ventyx Biosciences
1 follower
Edgewise Therapeutics
1 follower
nSide
3 followers
iECURE
1 follower
Twist Bioscience
8 followers
Discover companies